Journey Medical has claimed FDA approval for its Emrosi therapy for rosacea, which it thinks could become a "standard of care ...

Opens in a new tab or window The FDA approved minocycline hydrochloride extended-release capsules (Emrosi) for treating ...

Journey Medical's new rosacea treatment will rival industry giant Galderma's Oracea in the treatment of rosacea.

The FDA approved Emrosi (minocycline hydrochloride extended-release capsules) for the treatment of inflammatory lesions of ...

Journey Medical said on Monday the U.S. Food and Drug Administration has approved its drug for the treatment of a long-term ...

Dermatology drugmaker Journey Medical has trekked its Dr. Reddy’s Laboratories-partnered rosacea med across the FDA finish line as Emrosi. | The drug proved superiority in clearing lesions over ...

WORCESTER, Mass. - Mustang Bio, Inc. (NASDAQ:MBIO), een biofarmaceutisch bedrijf in de klinische fase, heeft van de U.S. Food and Drug Administration (FDA) de Orphan Drug Designation gekregen voor MB- ...

For a list of products with lower levels of benzene as well as alternatives for managing skin blemishes, you may wish to read our “eGuide to Acne Solutions.” This online resource may be found under ...

The FDA is set to decide on four promising therapies in the next two weeks, including a CAR T for acute lymphoblastic ...

Journey Medical (NASDAQ:DERM) shares are trading higher Monday after the company announced the U.S. Food and Drug ...

Journey Medical (DERM) received FDA approval for its drug Emrosi for the treatment of rosacea and released its preliminary Q3 ...